BenevolentAI Investor Conference Presentation Deck
Reported to Normalised¹
Reported operating loss
Adjustments for:
R&D - Restructuring programme expenses
G&A Restructuring programme expenses
G&A Direct Transaction costs
G&A - Transaction-related listing service SBP expense
G&A - Transaction-related employee-related SBP expense
G&A Transaction-related stamp duty
Normalised¹ group operating loss
1. Excludes exceptional costs related to the restructuring programme and
2022 Business Combination.
Six months ended
30 June
2023
£'000
(45,850)
4,052
1,238
(40,560)
BenevolentAl Proprietary
2022
£'000
(153,384)
11,255
83,067
3,883
3,740
(51,439)
The HY 2023 reported operating loss
driven in part by £5.3m non-recurring
provision for restructuring
programme undertaken across R&D
and G&A, reflecting full year costs
recognised at the point of
committing to the plan in May 2023.
These restructuring costs comprise:
• Staff costs
Professional fees
. Committed costs now onerous
Facility and equipment costs
associated with the downsizing
●
The HY 2022 reported operating loss
included the categorised costs related
to the Business Combination
Transaction.
Benevolent 21View entire presentation